载多柔比星微球经动脉化疗栓塞治疗不可手术或复发性结直肠癌
回顾性研究纳入12例组织学证实的结直肠癌患者,于2017年8月至2020年4月接受载多柔比星CalliSpheres®微球DEB-TACE。术后1个月全部患者局部疾病控制,3个月和6个月疾病控制率分别为90.9%和70.0%,中位总生存15.9个月,无严重并发症或手术相关死亡。结论认为DEB-TACE安全有效,可能成为不可手术或复发结直肠癌的治疗选择。
要点
- DEB-TACE术后1个月全部12例患者达到局部疾病控制
- 术后3个月和6个月疾病控制率分别为90.9%和70.0%
- 中位总生存15.9个月,中位无进展生存13.4个月,无严重并发症
核心结论
- DEB-TACE是安全有效的治疗方法,可能成为不可手术或复发性结直肠癌患者的一种选择。
研究设计与样本
- 回顾性研究,连续纳入12例经组织学证实的结直肠癌患者,于2017年8月至2020年4月接受载多柔比星CalliSpheres®微球DEB-TACE。
- 患者9例男性、3例女性,平均年龄62.5±14.9岁(范围29-84岁)。
- 回顾性分析患者特征、医学影像数据、并发症及DEB-TACE操作过程。
诊断标准与关键数值
- 疾病控制率定义为完全缓解、部分缓解和疾病稳定之和。
- DEB-TACE术后1个月全部患者显示局部疾病控制;3个月和6个月疾病控制率分别为90.9%和70.0%。
- 无进展间期为11.0至81.8个月;5例患者(41.7%)既往接受过化疗。
- 中位总生存15.9个月,中位无进展生存13.4个月。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to assess the safety and efficacy of transarterial chemoembolization (TACE) with doxorubicin-loaded CalliSpheres® beads (DEB-TACE) for the treatment of patients with inoperable or recurrent colorectal cancer (CRC).
METHODS: This retrospective study recruited 12 consecutive patients with histology confirmation of CRC who received DEB-TACE between August 2017 and April 2020. There were 9 male and 3 female, with a mean age 62.5 ± 14.9 (range 29-84). Patients' characteristics, medical imaging data, complications and DEB-TACE procedure were retrospectively reviewed. The disease control rate was defined as the sum of complete response, partial response and stable disease.
RESULTS: DEB-TACE was successfully performed in all patients. All patients showed local disease control 1 month after DEB-TACE. Disease control rates were 90.9% and 70.0% at 3 and 6 months after DEB-TACE procedure, respectively. Disease-free interval was 11.0 to 81.8 months. Five patients (41.7%) received prior chemotherapy treatments. No severe complications or procedure-related deaths were observed. The median overall survival was 15.9 months, and median progression-free survival was 13.4 months.
CONCLUSION: DEB-TACE is a safe and effective treatment and could be a option for patients with inoperable or recurred CRC.
引用
- Bi Y, Shi X, Ren J, et al. Transarterial chemoembolization with doxorubicin-loaded beads for inoperable or recurrent colorectal cancer. Abdom Radiol (NY). 2021. PMID: 33386908. doi:10.1007/s00261-020-02877-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。